Published in
Elsevier, Schizophrenia Research, 1-3(164), p. 136-142, 2015
DOI: 10.1016/j.schres.2015.01.041
Links
Tools
A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
Journal article published in 2015 by
L. Fredrik Jarskog,
L. Fredrik Jarskog,
Martin T. Lowy,
Richard A. Grove,
Richard S. E. Keefe,
Joseph P. Horrigan,
M. Patricia Ball 
,
M. Patricia Ball,
Alan Breier,
Robert W. Buchanan,
Cameron S. Carter,
John G. Csernansky,
Donald C. Goff,
Michael F. Green,
Joshua T. Kantrowitz
and other authors.
,
M. Patricia Ball,
Alan Breier,
Robert W. Buchanan,
Cameron S. Carter,
John G. Csernansky,
Donald C. Goff,
Michael F. Green,
Joshua T. Kantrowitz
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 